<?xml version="1.0" encoding="utf-8"?>
<!-- generator="wordpress/1.2.2" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
>

<channel>
	<title>Made-in-Switzerland.com News</title>
	<link>http://www.made-in-switzerland.com/News</link>
	<description>Latest  news &#038; information about Swiss companies - Press releases</description>
	<copyright>Copyright 2007</copyright>
	<pubDate>Thu, 19 Apr 2007 08:48:27 +0000</pubDate>
	<generator>http://wordpress.org/?v=1.2.2</generator>

		<item>
		<title>ABB files Form 20-F for 2006 with U.S. Securities and Exchange Commission</title>
		<link>http://www.made-in-switzerland.com/News/index.php?p=1194</link>
		<comments>http://www.made-in-switzerland.com/News/index.php?p=1194#comments</comments>
		<pubDate>Thu, 19 Apr 2007 08:48:27 +0000</pubDate>
		
	<category>General</category>		<guid>http://www.made-in-switzerland.com/News/index.php?p=1194</guid>
		<description>ABB files Form 20-F for 2006 with U.S. Securities and Exchange Commission

Zurich, Switzerland, April 19, 2007- ABB Ltd. has filed its annual report on Form 20-F with the United States Securities and Exchange Commission. The report is available in pdf format at www.abb.com/news or www.abb.com/investorrelations.

Shareholders may request a hard copy ...</description>
		<wfw:commentRSS>http://www.made-in-switzerland.com/News/wp-commentsrss2.php?p=1194</wfw:commentRSS>
	</item>
		<item>
		<title>Lonza continues growth in biopharmaceuticals</title>
		<link>http://www.made-in-switzerland.com/News/index.php?p=1193</link>
		<comments>http://www.made-in-switzerland.com/News/index.php?p=1193#comments</comments>
		<pubDate>Thu, 19 Apr 2007 08:46:43 +0000</pubDate>
		
	<category>General</category>
	<category>Pharmaceutical</category>		<guid>http://www.made-in-switzerland.com/News/index.php?p=1193</guid>
		<description>Lonza, the global life sciences company, announces the groundbreaking plans for the expansion of its Portsmouth, N.H. (USA) mammalian biopharmaceutical manufacturing facility.

Following the start of construction of Lonza’s second large-scale mammalian facility in Singapore which took place at the end of March 2007, the expansion continues. On May 17th 2007, ...</description>
		<wfw:commentRSS>http://www.made-in-switzerland.com/News/wp-commentsrss2.php?p=1193</wfw:commentRSS>
	</item>
		<item>
		<title>Logitech Delivers Ninth Consecutive Record Year</title>
		<link>http://www.made-in-switzerland.com/News/index.php?p=1192</link>
		<comments>http://www.made-in-switzerland.com/News/index.php?p=1192#comments</comments>
		<pubDate>Thu, 19 Apr 2007 08:46:08 +0000</pubDate>
		
	<category>General</category>		<guid>http://www.made-in-switzerland.com/News/index.php?p=1192</guid>
		<description>Logitech International announced it has posted its ninth consecutive year of record sales and profits. The Company closed the fiscal year with a record fourth quarter — its 34th consecutive quarter of double-digit revenue growth — and achieved its upwardly revised full-year goal for operating income while falling short of ...</description>
		<wfw:commentRSS>http://www.made-in-switzerland.com/News/wp-commentsrss2.php?p=1192</wfw:commentRSS>
	</item>
		<item>
		<title>Simply perfect all along the line: Leica LINO™ L2 – the perfect alignment tool</title>
		<link>http://www.made-in-switzerland.com/News/index.php?p=1191</link>
		<comments>http://www.made-in-switzerland.com/News/index.php?p=1191#comments</comments>
		<pubDate>Thu, 19 Apr 2007 08:45:18 +0000</pubDate>
		
	<category>General</category>		<guid>http://www.made-in-switzerland.com/News/index.php?p=1191</guid>
		<description>Leica Geosystems has been very successfully in the laser measuring sector for some time with the laser distance meter Leica DISTOTM. We have now used our extensive experience to develop a line-laser that sets new standards: Leica LINO™ L2. The usage of excellent optical components to proven Leica Geosystems quality ...</description>
		<wfw:commentRSS>http://www.made-in-switzerland.com/News/wp-commentsrss2.php?p=1191</wfw:commentRSS>
	</item>
		<item>
		<title>Converium triples income from continuing operations in the first quarter of 2007 and reports significant progress in pursuing its strategic roadmap</title>
		<link>http://www.made-in-switzerland.com/News/index.php?p=1190</link>
		<comments>http://www.made-in-switzerland.com/News/index.php?p=1190#comments</comments>
		<pubDate>Thu, 19 Apr 2007 08:44:32 +0000</pubDate>
		
	<category>General</category>		<guid>http://www.made-in-switzerland.com/News/index.php?p=1190</guid>
		<description>Converium triples income from continuing operations in the first quarter of 2007 and reports significant progress in pursuing its strategic roadmap.

    * Income from continuing operations of USD 150.9 million, up from USD 49.9 million in the first quarter of 2006, despite an adverse impact of USD ...</description>
		<wfw:commentRSS>http://www.made-in-switzerland.com/News/wp-commentsrss2.php?p=1190</wfw:commentRSS>
	</item>
		<item>
		<title>Breakthrough cancer drug Avastin approved in Japan for use in advanced or recurrent colorectal cancer</title>
		<link>http://www.made-in-switzerland.com/News/index.php?p=1189</link>
		<comments>http://www.made-in-switzerland.com/News/index.php?p=1189#comments</comments>
		<pubDate>Wed, 18 Apr 2007 10:37:38 +0000</pubDate>
		
	<category>General</category>
	<category>Pharmaceutical</category>		<guid>http://www.made-in-switzerland.com/News/index.php?p=1189</guid>
		<description>Chugai, a member of the Roche Group, announced that marketing approval has been granted for the use of the breakthrough cancer drug Avastin (bevacizumab) in patients with inoperable advanced or recurrent colorectal cancer in Japan.

The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted this approval following the recommendation ...</description>
		<wfw:commentRSS>http://www.made-in-switzerland.com/News/wp-commentsrss2.php?p=1189</wfw:commentRSS>
	</item>
		<item>
		<title>Roche posts strong first quarter sales – upgrade of Core Earnings per Share outlook for 2007</title>
		<link>http://www.made-in-switzerland.com/News/index.php?p=1188</link>
		<comments>http://www.made-in-switzerland.com/News/index.php?p=1188#comments</comments>
		<pubDate>Wed, 18 Apr 2007 10:37:10 +0000</pubDate>
		
	<category>General</category>
	<category>Pharmaceutical</category>		<guid>http://www.made-in-switzerland.com/News/index.php?p=1188</guid>
		<description>Roche Group

    * Group sales grew 17% in local currencies and 16% in Swiss francs to 11.4 billion Swiss francs
    * Outlook upgraded: Core Earnings per Share now expected to grow above Group sales growth

Pharmaceuticals Division

    * Pharmaceutical sales up 20% ...</description>
		<wfw:commentRSS>http://www.made-in-switzerland.com/News/wp-commentsrss2.php?p=1188</wfw:commentRSS>
	</item>
		<item>
		<title>Emmi - Rapid growth and stronger market positions</title>
		<link>http://www.made-in-switzerland.com/News/index.php?p=1187</link>
		<comments>http://www.made-in-switzerland.com/News/index.php?p=1187#comments</comments>
		<pubDate>Wed, 18 Apr 2007 10:36:18 +0000</pubDate>
		
	<category>General</category>		<guid>http://www.made-in-switzerland.com/News/index.php?p=1187</guid>
		<description>For Emmi, 2006 was distinguished by rapid growth, stronger market positions and reinforced competitiveness. Net sales rose to CHF 2,335 million, corresponding to growth of 15.2%. Despite dilution due to acquisitions, Emmi posted net profit of CHF 54.0 million, up CHF 2.6 million on the previous year, and a net ...</description>
		<wfw:commentRSS>http://www.made-in-switzerland.com/News/wp-commentsrss2.php?p=1187</wfw:commentRSS>
	</item>
		<item>
		<title>A revolutionary solution from BOBST for embossing Braille using a folder-gluer</title>
		<link>http://www.made-in-switzerland.com/News/index.php?p=1186</link>
		<comments>http://www.made-in-switzerland.com/News/index.php?p=1186#comments</comments>
		<pubDate>Wed, 18 Apr 2007 10:33:41 +0000</pubDate>
		
	<category>General</category>		<guid>http://www.made-in-switzerland.com/News/index.php?p=1186</guid>
		<description>The Swiss manufacturer presents its solutions for the pharmaceutical packaging industry

BOBST recently organized an open house at its Mex factory, near Lausanne (Switzerland), which focused on solutions for pharmaceutical packaging converting. Over two days, more than 170 visitors from 90 companies had the opportunity to see in detail the latest ...</description>
		<wfw:commentRSS>http://www.made-in-switzerland.com/News/wp-commentsrss2.php?p=1186</wfw:commentRSS>
	</item>
		<item>
		<title>Swiss companies have to make bigger efforts to prepare for demographic change</title>
		<link>http://www.made-in-switzerland.com/News/index.php?p=1185</link>
		<comments>http://www.made-in-switzerland.com/News/index.php?p=1185#comments</comments>
		<pubDate>Tue, 17 Apr 2007 20:54:06 +0000</pubDate>
		
	<category>General</category>		<guid>http://www.made-in-switzerland.com/News/index.php?p=1185</guid>
		<description>The Adecco Institute for the first time presents the Demographic Fitness Index for Swiss companies; Switzerland only ranks 7th among 8 countries
 
Swiss companies are less prepared for their ageing workforce than the average of selected European Union member states. In the comparison with 7 EU countries (UK, France, Italy, ...</description>
		<wfw:commentRSS>http://www.made-in-switzerland.com/News/wp-commentsrss2.php?p=1185</wfw:commentRSS>
	</item>
	</channel>
</rss>
